Hunan Ouya pharmaceuical Co., Ltd. was established in November 2007,located at Changsha national biological industry base. We are prfessional toproduce APls and intermediates of Anti-Cancer, Cardiovascular, Digestion, Antiviraland so on.Tract our company owns 18 independent intlll property rights, hasapplied more than 40 inventive patents, and was recognized as the technologicalinovation enterprise, Hunan high-tech enterprise. Ouya technology center has beenrecognized as the Changsha Enterprise Technology Center, and a plurality of projectshave won as the key scientific and technological research projects of the state andprovinces.
Hunan Ouya Pharmaceutical owns a professional talent team, and focuses on the scientific research and market maintenance, wherein the highly-educatedpersonnel are over 70% of the total members, and the R & D personnel are over 36%.Simultaneously, our company work closely with several universities and scientificresearch institutes, continuously develop products with competitive advantages,cooperate with the domestic and foreign pharmaceutical companies.
In 2018, Ouya established the GMP workshop and the GMP system. In 2019, thedrug production license was granted, which officially open a new step of APIproduction. Ouya always advocates innovative science and technology, insists theoperation philosophy with environmental protect, healthy and sustained economicdevelopment, pays great attention to innovation and scientific research and themarket maintenance, strictly controls the product quality, improves customer service ,and dedicates to provide our advantage products and customized service to ourdomestic and foreign pharmaceutical companies.
Hunan Ouya Pharmaceutical owns a professional talent team, and focuses on the scientific research and market maintenance, wherein the highly-educatedpersonnel are over 70% of the total members, and the R & D personnel are over 36%.Simultaneously, our company work closely with several universities and scientificresearch institutes, continuously develop products with competitive advantages,cooperate with the domestic and foreign pharmaceutical companies.
In 2018, Ouya established the GMP workshop and the GMP system. In 2019, thedrug production license was granted, which officially open a new step of APIproduction. Ouya always advocates innovative science and technology, insists theoperation philosophy with environmental protect, healthy and sustained economicdevelopment, pays great attention to innovation and scientific research and themarket maintenance, strictly controls the product quality, improves customer service ,and dedicates to provide our advantage products and customized service to ourdomestic and foreign pharmaceutical companies.
